GlassScriptPhysician profile
Atif Shaikh
NPI 1144568312
$957.85
in general payments reported to CMS, 2019-2025
8 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $43.49 · 2021: $48.74 · 2022: $72.73 · 2023: $202 · 2024: $312 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $468.17 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $262.78 | 2023-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.04 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $56.57 | 2021-2022 | |
| Medtronic, INC. | $40.00 | 2023 | Onyx Frontier |
| Abbvie INC. | $25.17 | 2023 | Botox |
| Novartis Pharmaceuticals Corporation | $16.65 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $15.47 | 2023 | Brilinta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atif Shaikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.